# Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pre-treatment-with-the-cdk4-6-inhibitor-palbociclib-improves-the-efficacy-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Daniele Cretella,Claudia Fumarola,Mara Bonelli,Roberta Alfieri,Silvia La Monica,Graziana Digiacomo,Andrea Cavazzoni,Maricla Galetti,Daniele Generali,Pier Giorgio Petronini |
| Citations | 87 |
| DOI | 10.1038/s41598-019-49484-4 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.nature.com/articles/s41598-019-49484-4.pdf |
| OpenAlex ID | https://openalex.org/W2973025790 |
| PMID | 31506466 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Silvia La Monica](https://scholariq.org/researchers/silvia-la-monica/)

## Paper journal

- [Scientific Reports](https://scholariq.org/journals/scientific-reports/)

## Paper primary topic

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Paper topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.